Compare CLPS & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLPS | YI |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | Hong Kong | China |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Retail-Drug Stores and Proprietary Stores |
| Sector | Technology | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.6M | 30.5M |
| IPO Year | 2017 | 2018 |
| Metric | CLPS | YI |
|---|---|---|
| Price | $1.06 | $3.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 18.0K | 4.9K |
| Earning Date | 03-06-2026 | 04-09-2026 |
| Dividend Yield | ★ 14.76% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.80 | $2.48 |
| 52 Week High | $1.88 | $11.17 |
| Indicator | CLPS | YI |
|---|---|---|
| Relative Strength Index (RSI) | 63.60 | 37.57 |
| Support Level | $0.84 | $2.48 |
| Resistance Level | $1.12 | $4.01 |
| Average True Range (ATR) | 0.05 | 0.28 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 84.24 | 31.54 |
CLPS Inc. is an IT consulting and solutions provider serving international clients in the banking, wealth management, e-commerce, and automotive sectors. The company drives digital transformation using AI, cloud computing, and big data, offering IT consulting, customized solutions, virtual banking training, recruitment, professional training, and software services. It operates mainly in two segments: IT services, which generate the majority of its revenue, and academic education services. The company has a presence in Hong Kong, Singapore, Mainland China, India, Malaysia, and Japan, with the majority of its revenue coming from Mainland China.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.